Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert ...

G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and one of the most successful therapeutic targets in modern medicine, with approximately 34% of FDA-approved ...

Our body receives and processes a vast number of signals. Chemical signals serve as guidance cues and ensure, for example, ...

Across multiple solid tumors, glucagon-like peptide 1 receptor agonist (GLP-1 RA) initiation after cancer diagnosis is ...

A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...

A recent study published in Engineering delves into the complex mechanisms of drug addiction, highlighting the crucial role of astrocytic G protein-coupled receptors (GPCRs). This research offers ...

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...

Glucagon-like peptide-1 (GLP-1) was first discovered in the 1980s as a regulator of glucose levels. Further research led to the creation of a stabilized GLP-1RA called semaglutide, the active ...

A study by researchers at Duke University School of Medicine identifies a new way that G protein–coupled receptors ...

When Terra Field started taking Wegovy for weight loss in 2022, she finally understood what satiety truly felt like. “It felt the way I thought my body should have been operating the entire time,” ...

A doctor's greater concern, she said, is not the drug itself but how patients obtain it.